Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/AKT Signaling Pathways

Agosti E, Panciani PP, Zeppieri M, De Maria L, Pasqualetti F, Tel A, Zanin L, Fontanella MM, Ius T (2023) Tumor microenvironment and glioblastoma cell interplay as promoters of therapeutic resistance. Biology (Basel) 12:736

CAS  PubMed  Google Scholar 

Akhave NS, Biter AB, Hong DS (2021) Mechanisms of Resistance to KRAS(G12C)-Targeted Therapy. Cancer Discov 11:1345–1352

CAS  PubMed  PubMed Central  Google Scholar 

Alves CL, Ditzel HJ (2023) Drugging the PI3K/AKT/mTOR pathway in ER+ breast cancer. Int J Mol Sci 24:4522

CAS  PubMed  PubMed Central  Google Scholar 

Ashrafizadeh M, Zarrabi A, Mostafavi E, Aref AR, Sethi G, Wang L, Tergaonkar V (2022) Non-coding RNA-based regulation of inflammation. Semin Immunol 59:101606

CAS  PubMed  Google Scholar 

Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, Slack FJ (2012) Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A 109:E1695-1704

CAS  PubMed  PubMed Central  Google Scholar 

Bader AG, Kang S, Zhao L, Vogt PK (2005) Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5:921–929

CAS  PubMed  Google Scholar 

Benetatos L, Voulgaris E, Vartholomatos G (2017) The crosstalk between long non-coding RNAs and PI3K in cancer. Med Oncol 34:39

PubMed  Google Scholar 

Bianchi ME, Mezzapelle R (2020) The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration. Front Immunol 11:2109

CAS  PubMed  PubMed Central  Google Scholar 

Cao T, Cui Y, Wang Y, Wu L, Yu K, Chen K, Xia J, Li Y, Wang ZP, Ma J (2022) CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K/AKT/mTOR pathways in glioma. Apoptosis 27:979–991

Google Scholar 

Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I (2011) A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147:358–369

CAS  PubMed  PubMed Central  Google Scholar 

Chai B, Ma Z, Wang X, Xu L, Li Y (2022) Functions of non-coding RNAs in regulating cancer drug targets. Acta Biochim Biophys Sin (shanghai) 54:279–291

CAS  PubMed  Google Scholar 

Chandra Gupta S, Nandan Tripathi Y (2017) Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets. Int J Cancer 140:1955–1967

CAS  PubMed  Google Scholar 

Chen Q, Cai J, Wang Q, Wang Y, Liu M, Yang J, Zhou J, Kang C, Li M, Jiang C (2018) Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2. Clin Cancer Res 24:684–695

CAS  PubMed  Google Scholar 

Chen Q, Wang W, Wu Z, Chen S, Chen X, Zhuang S, Song G, Lv Y, Lin Y (2021) Over-expression of lncRNA TMEM161B-AS1 promotes the malignant biological behavior of glioma cells and the resistance to temozolomide via up-regulating the expression of multiple ferroptosis-related genes by sponging hsa-miR-27a-3p. Cell Death Discov 7:311

CAS  PubMed  PubMed Central  Google Scholar 

Cheng J, Meng J, Zhu L, Peng Y (2020a) Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications. Mol Cancer 19:66

CAS  PubMed  PubMed Central  Google Scholar 

Cheng Z, Luo C, Guo Z (2020b) LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma. J Cell Biochem 121:2170–2183

CAS  PubMed  Google Scholar 

Choi HI, An GY, Yoo E, Baek M, Chai JC, Binas B, Lee YS, Jung KH, Chai YG (2022) Targeting of noncoding RNAs encoded by a novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro. Sci Rep 12:855

CAS  PubMed  PubMed Central  Google Scholar 

Curtin JC, Lorenzi MV (2010) Drug discovery approaches to target Wnt signaling in cancer stem cells. Oncotarget 1:563–577

PubMed  PubMed Central  Google Scholar 

Dahlmanns M, Yakubov E, Dahlmanns JK (2021) Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction. Front Oncol 11:783067

CAS  PubMed  PubMed Central  Google Scholar 

Dai B, Xiao Z, Mao B, Zhu G, Huang H, Guan F, Su H, Lin Z, Peng W, Hu Z (2019) lncRNA AWPPH promotes the migration and invasion of glioma cells by activating the TGF-β pathway. Oncol Lett 18:5923–5929

CAS  PubMed  PubMed Central  Google Scholar 

Deveson IW, Hardwick SA, Mercer TR, Mattick JS (2017) The Dimensions, Dynamics, and Relevance of the Mammalian Noncoding Transcriptome. Trends Genet 33:464–478

CAS  PubMed  Google Scholar 

Ding M, Xu Q, Jin X, Han Z, Jiang H, Sun H, Jin Y, Piao Z, Zhang S (2023) Novel exosome-related risk signature as prognostic biomarkers in glioblastoma. Front Immunol 14:1071023

CAS  PubMed  PubMed Central  Google Scholar 

Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060–1072

CAS  PubMed  PubMed Central  Google Scholar 

Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, Xue C, Marinov GK, Khatun J, Williams BA, Zaleski C, Rozowsky J, Röder M, Kokocinski F, Abdelhamid RF, Alioto T, Antoshechkin I, Baer MT, Bar NS, Batut P, Bell K, Bell I, Chakrabortty S, Chen X, Chrast J, Curado J, Derrien T, Drenkow J, Dumais E, Dumais J, Duttagupta R, Falconnet E, Fastuca M, Fejes-Toth K, Ferreira P, Foissac S, Fullwood MJ, Gao H, Gonzalez D, Gordon A, Gunawardena H, Howald C, Jha S, Johnson R, Kapranov P, King B, Kingswood C, Luo OJ, Park E, Persaud K, Preall JB, Ribeca P, Risk B, Robyr D, Sammeth M, Schaffer L, See LH, Shahab A, Skancke J, Suzuki AM, Takahashi H, Tilgner H, Trout D, Walters N, Wang H, Wrobel J, Yu Y, Ruan X, Hayashizaki Y, Harrow J, Gerstein M, Hubbard T, Reymond A, Antonarakis SE, Hannon G, Giddings MC, Ruan Y, Wold B, Carninci P, Guigó R, Gingeras TR (2012) Landscape of transcription in human cells. Nature 489:101–108

CAS  PubMed  PubMed Central  Google Scholar 

Du L, Lee JH, Jiang H, Wang C, Wang S, Zheng Z, Shao F, Xu D, Xia Y, Li J, Zheng Y, Qian X, Li X, Kim H.R, Xing D, Liu P, Lu Z, Lyu J (2020) β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion. J Exp Med 217:e20191115

CAS  PubMed  PubMed Central  Google Scholar 

Duan Y, Haybaeck J, Yang Z (2020) Therapeutic Potential of PI3K/AKT/mTOR pathway in gastrointestinal stromal tumors: rationale and progress. Cancers (Basel) 12:2972

CAS  PubMed  Google Scholar 

Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE, Vader P (2020) Extracellular vesicles as drug delivery systems: Why and how? Adv Drug Deliv Rev 159:332–343

CAS  PubMed  Google Scholar 

Fearnhead HO, Vandenabeele P, Vanden Berghe T (2017) How do we fit ferroptosis in the family of regulated cell death? Cell Death Differ 24:1991–1998

CAS  PubMed  PubMed Central  Google Scholar 

Federman N (2022) Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition. NPJ Precis Oncol 6:62

CAS  PubMed  PubMed Central  Google Scholar 

Filley AC, Henriquez M, Dey M (2017) Recurrent glioma clinical trial, CheckMate-143: the game is not over yet. Oncotarget 8:91779–91794

PubMed  PubMed Central  Google Scholar 

Gajos-Michniewicz A, Czyz M (2020) WNT signaling in Melanoma. Int J Mol Sci 21:4852

CAS  Google Scholar 

Gao XF, He HQ, Zhu XB, Xie SL, Cao Y (2019) LncRNA SNHG20 promotes tumorigenesis and cancer stemness in glioblastoma via activating PI3K/Akt/mTOR signaling pathway. Neoplasma 66:532–542

CAS  PubMed  Google Scholar 

Gao XY, Zang J, Zheng MH, Zhang YF, Yue KY, Cao XL, Cao Y, Li XX, Han H, Jiang XF, Liang L (2021) Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma. Front Cell Dev Biol 9:620883

PubMed  PubMed Central  Google Scholar 

Ghiaseddin AP, Shin D, Melnick K, Tran DD (2020) Tumor Treating Fields in the Management of Patients with Malignant Gliomas. Curr Treat Options Oncol 21:76

PubMed  PubMed Central  Google Scholar 

Goker Bagca B, Ozates NP, Biray Avci C (2022) Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes. Med Oncol 40:37

PubMed  Google Scholar 

Gong X, Liao X, Huang M (2019) LncRNA CASC7 inhibits the progression of glioma via regulating Wnt/β-catenin signaling pathway. Pathol Res Pract 215:564–570

CAS  PubMed  Google Scholar 

Guo LP, Zhang ZJ, Li RT, Li HY, Cui YQ (2019) Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci 23:253–261

PubMed  Google Scholar 

Guo A, Fang G, Lin Z, Zheng S, Zhuang Z, Lin R, Lin Y (2022) Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-κB signaling pathway. Histol Histopathol 37:543–554

CAS  PubMed  Google Scholar 

Guttman M, Rinn JL (2012) Modular regulatory principles of large non-coding RNAs. Nature 482:339–346

CAS  PubMed  PubMed Central  Google Scholar 

Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, Cabili MN, Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N, Bernstein BE, Kellis M, Regev A, Rinn JL, Lander ES (2009) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458:223–227

CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif